Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-29 Purchase |
2021-12-01 11:06 am |
Eloxx Pharmaceuticals Inc. | ELOX | Geffken Daniel E. INTERIM CFO |
50,000 | $0.72 | $36,000 | 50,000 (Direct) |
View |
| 2020-05-22 Purchase |
2020-05-27 9:36 pm |
WINDTREE THERAPEUTICS INC | WINT | Geffken Daniel E. Director |
2,069 | $7.25 | $15,000 | 4,138 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-17 Option Award |
2024-05-20 7:47 pm |
N/A 2034-05-16 |
CalciMedica Inc. | CALC | Geffken Daniel E. Interim CFO |
10,000 | $0 | 10,000 (Indirect) |
View |
| 2024-02-14 Other |
2024-02-16 7:39 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Geffken Daniel E. Chief Financial Officer |
10,002 | $0 | 20,004 (Direct) |
View |
| 2023-10-26 Option Award |
2023-10-30 7:42 pm |
N/A 2033-10-26 |
ProMIS Neurosciences Inc. | PMN | Geffken Daniel E. Chief Financial Officer |
2,500 | $0 | 2,500 (Direct) |
View |
| 2023-08-23 Option Award |
2023-08-29 4:37 pm |
N/A 2033-08-23 |
WINDTREE THERAPEUTICS INC | WINT | Geffken Daniel E. Director |
5,083 | $0 | 5,225 (Direct) |
View |
| 2023-03-20 Option Award |
2023-05-03 8:59 pm |
N/A 2030-11-09 |
CalciMedica Inc. | CALC | Geffken Daniel E. Interim CFO |
17,280 | $0 | 17,280 (Indirect) |
View |
Ownership |
2023-05-03 8:55 pm |
N/A 2029-12-11 |
CalciMedica Inc. | CALC | Geffken Daniel E. Interim CFO |
0 | $0 | 1,982 (Indirect) |
View |
Ownership |
2022-07-07 7:28 pm |
N/A N/A |
ProMIS Neurosciences Inc. | PMN | Geffken Daniel E. Chief Financial Officer |
0 | $0 | 23,560 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 8:13 pm |
2023-06-07 2032-06-07 |
WINDTREE THERAPEUTICS INC | WINT | Geffken Daniel E. Director |
12,500 | $0 | 14,569 (Direct) |
View |
| 2021-10-08 Other |
2021-10-12 7:35 pm |
N/A N/A |
PHOENIX BIOTECH ACQUISITION CORP. | PBAX | Geffken Daniel E. Chief Financial Officer |
30,000 | $0 | 30,000 (Indirect) |
View |
| 2021-06-15 Option Award |
2021-06-17 8:02 pm |
2022-06-15 2031-06-15 |
WINDTREE THERAPEUTICS INC | WINT | Geffken Daniel E. Director |
15,000 | $0 | 17,069 (Direct) |
View |
| 2021-04-20 Option Award |
2021-04-22 11:55 am |
N/A 2026-04-20 |
Eloxx Pharmaceuticals Inc. | ELOX | Geffken Daniel E. CHIEF FINANCIAL OFFICER |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 9:11 pm |
2021-02-03 2031-02-03 |
WINDTREE THERAPEUTICS INC | WINT | Geffken Daniel E. Director |
15,000 | $0 | 17,069 (Direct) |
View |
| 2021-01-12 Other |
2021-01-14 7:49 pm |
N/A N/A |
Locust Walk Acquisition Corp. | LWAC | Geffken Daniel E. Chief Financial Officer |
20,000 | $0 | 20,000 (Indirect) |
View |